Sale of 2,857 shares at $25.07 per share.
Reporting Person Schuth Alexander O. · Officer Title COFO and Secretary · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001724311-26-000013 · filed 2026-08-13 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Denali Therapeutics Inc. (DNLI)." Disclosed 2026-08-13. https://desqlong.com/cards/0001724311-26-000013-1 (retrieved 2026-09-26).